Verastem stock trades at EUR 8.55 on Lang & Schwarz
Published on 11/03/2026 at 13:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBusiness Focus And Upcoming Results
- Verastem focuses on medicines for cancers driven by RAS/MAPK signaling.
- The company is scheduled to report its next quarterly results on November 5, 2026.
Verastem stock traded at EUR 8.55 on Lang & Schwarz at 13:43 CET on Tuesday, November 3, 2026.
Results Remain The Next Catalyst
Verastem is a biotechnology company focused on medicines for cancers driven by RAS/MAPK signaling. Its next quarterly results are scheduled for Thursday, November 5, 2026.
For investors, the upcoming report is the next scheduled company event. The results may provide the next indication of progress in the company's development programs and commercial activities.
Investors can follow the real-time quote of Verastem stock for the latest Lang & Schwarz trading reference.
Verastem stock snapshot
- Company: Verastem
- ISIN: US92337C2035
- Ticker: VSTM
- Venue: Lang & Schwarz
- Quote: EUR 8.55 at 13:43 CET on November 3, 2026
US equities can be followed through the S&P 500 market page.
More news and analyses on Verastem stock are available on the company's topic page.
Disclaimer...
en | US92337C2035 | VSTM | boerse | 70450587 |
